Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-01-13

Clinical Trial Update: Role of ChatGPT in Vestibular Schwannoma Management [NA]

View source ↗

Summary

A clinical trial investigating the use of ChatGPT in vestibular schwannoma management has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Southern California | Conditions: Vestibular Schwannoma | NA | Status: WITHDRAWN